A
$ Value
$0
Shares
80,000
Price
$0
Filed
Feb 10
Insider
Name
Klein Uwe
Title
SVP, Biological Sciences
CIK
0002040350
Roles
Officer
Transaction Details
Transaction Date
2026-02-06
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
80,000
Footnotes
2/48th of the shares subject to such option shall vest and become exercisable on March 1, 2026 and the remaining shares subject to the option shall vest in 46 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Filing Info
Klein Uwe's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-06 | SEPN | A | $0 |
| 2025-08-18 | SEPN | M | $29K |
| 2025-08-18 | SEPN | M | $14K |
| 2025-08-18 | SEPN | M | $52K |
| 2025-08-18 | SEPN | M | $0 |
| 2025-08-18 | SEPN | M | $0 |
| 2025-08-18 | SEPN | M | $0 |
| 2025-08-07 | SEPN | A | $0 |
Other Insiders at SEPN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Labrucherie Gil M
Chief Financial Officer
|
— | — | 2026-02-06 |
|
Bhatt Elizabeth
President and COO
|
— | $213K | 2026-04-15 |
|
Wilson Mark Andrew
Chief Legal Officer
|
— | — | 2026-02-06 |
|
Kim Jae B.
Chief Medical Officer
|
— | — | 2026-02-06 |
|
Long Daniel D.
SVP, Drug Discovery
|
— | — | 2026-02-06 |
|
Shaikhly Samira
Chief People Officer
|
— | — | 2026-02-06 |
|
Finer Jeffrey
Chief Executive Officer
|
— | — | 2026-02-06 |